K Mathur1, M K Ayyappan1, J Hodson2, J Hopkins3, A Tiwari1, M Duddy3, Rajiv Vohra4. 1. Department of Vascular Surgery, Queen Elizabeth Hospital, Birmingham, United Kingdom. 2. Wolfson Computer Laboratory, Queen Elizabeth Hospital, Birmingham, United Kingdom. 3. Department of Interventional Vascular Radiology, Queen Elizabeth Hospital, Birmingham, United Kingdom. 4. Department of Vascular Surgery, Queen Elizabeth Hospital, Birmingham, United Kingdom rajiv@vohra.org.uk.
Abstract
OBJECTIVES: To study factors affecting patency and medium-term outcomes after crural angioplasty. MATERIALS AND METHODS: All crural angioplasties between March 2003 and September 2010 were reviewed from a prospective database to analyze primary patency, amputation-free survival, and limb salvage. RESULTS: Five hundred and twenty-seven limbs in 478 patients (58.7% male, mean age 73.9 ± 0.53 years) were treated. In all, 49.1% were diabetic patients and 7.4% were dialysis dependent. Primary patency was 65.5%, 57.8%, 48.5%, and 32.9% at 1, 6, 12, and 36 months, respectively. Amputation-free survival was 75.2% at 1 year and 59.0% at 3 years. Limb salvage at 3 years was 92.7%. Rutherford categories 5 and 6 had a consistent adverse effect on patency. This led to an adverse amputation-free survival and limb salvage at 3 years. CONCLUSION: Crural angioplasty is an effective treatment for limb salvage. Its outcomes are adversely affected by diabetes, renal disease, coronary disease, and worsening Rutherford grade.
OBJECTIVES: To study factors affecting patency and medium-term outcomes after crural angioplasty. MATERIALS AND METHODS: All crural angioplasties between March 2003 and September 2010 were reviewed from a prospective database to analyze primary patency, amputation-free survival, and limb salvage. RESULTS: Five hundred and twenty-seven limbs in 478 patients (58.7% male, mean age 73.9 ± 0.53 years) were treated. In all, 49.1% were diabeticpatients and 7.4% were dialysis dependent. Primary patency was 65.5%, 57.8%, 48.5%, and 32.9% at 1, 6, 12, and 36 months, respectively. Amputation-free survival was 75.2% at 1 year and 59.0% at 3 years. Limb salvage at 3 years was 92.7%. Rutherford categories 5 and 6 had a consistent adverse effect on patency. This led to an adverse amputation-free survival and limb salvage at 3 years. CONCLUSION: Crural angioplasty is an effective treatment for limb salvage. Its outcomes are adversely affected by diabetes, renal disease, coronary disease, and worsening Rutherford grade.
Authors: Sanne M Schreuder; Yvette M G A Hendrix; Jim A Reekers; Shandra Bipat Journal: Cardiovasc Intervent Radiol Date: 2017-09-18 Impact factor: 2.740